In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T.
Overview
- Goethe University Frankfurt, University Hospital, Institute of Neuroradiology and Cooperative Brain Imaging Center - CoBIC, Frankfurt am Main, Germany
- University Cancer Center Frankfurt (UCT), Frankfurt am Main, Germany
- Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany
- German Cancer Research Center (DKFZ) Heidelberg, Germany and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany
- Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt am Main, Germany
- Goethe University Frankfurt, University Hospital, Institute of Neurology (Edinger-Institute), Frankfurt am Main, Germany
- Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Frankfurt am Main, Germany
- Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, USA
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD USA
Abstract
Background: Isocitrate dehydrogenase-wildtype glioblastoma (IDHwtGB) is the most common primary malignant brain tumor in adults, with a universally poor prognosis. For survival and growth under conditions of the tumor microenvironment, glioblastoma cells require antioxidant glutathione (GSH) and its metabolic precursor cystathionine (Cth) to maintain redox balance. We aimed to characterize GSH and Cth in vivo, in IDHwtGB patients, using edited MR spectroscopy (MRS). Our goal was to evaluate their tumor-molecular-status-d
Methods: In this prospective study (January 2023 - July 2025), 5 healthy subjects and 27 patients with MRI-suspected glioma were scanned on a 3T MR scanner using single-voxel MEGA-sLASER MRS. Tumoral and contralateral metabolite concentrations were compared using linear mixed models. Associations between tumoral GSH and other metabolite concentrations, as well as tumor subregion fractions, were assessed via multiple linear regression. Spearman correlation was used to evaluate the association between GSH and p53 immunoreactivity. The GSH concentration was compared across MGMT status and molecular subtypes with the Wilcoxon rank-sum test.
Results: A good scan-rescan reproducibility was observed in metabolite quantification in healthy subjects. Fifteen patients with IDHwtGB and high-quality spectra (mean age 59 ± 11 years; 9 men) were included in the final analysis. Tumor tissue exhibited significantly elevated Cth (1.17 ± 1.30 mM vs. 0.63 ± 0.59 mM, p = 0.03) and lower gamma-aminobutyric acid levels (2.36 ± 0.70 mM vs. 3.04 ± 0.89 mM, p = 0.006) compared to contralateral. Tumoral GSH concentrations correlated positively with Cth (p < 0.001) and enhancing-tumor fraction (p < 0.001), and negatively with p53 accumulation (p = 0.008). No difference in GSH levels was observed with respect to MGMT status (p = 0.66), whereas lower GSH concentrations were found in the mesenchymal subtype (p = 0.04).
Conclusions: GSH and Cth show promise as in vivo MRS biomarkers for therapies aimed at modulating redox balance.
Trial registration: German Clinical Trials Register (DRKS00032097), retrospectively registered on 25 November 2024.
Supplementary Information: The online version contains supplementary material available at 10.1186/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Data availability
MRS result tables and statistical analysis code that support the findings of this study are available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 14 authors, 1 funder, 34 references.
Cite
This paper
Alcicek, S., Manzhurtsev, A., Thomas, D. C., Divé, I., Weber, K. J., Prinz, V., Jussen, D., Deelchand, D. K., Oeltzschner, G., Ronellenfitsch, M. W., Steinbach, J. P., Hattingen, E., Pilatus, U., & Wenger, K. J. (2026). In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T. Cancer & metabolism, 14(1), 10. https://
BibTeX
@article{alcicek2026vivo
author = {Alcicek, Seyma and Manzhurtsev, Andrei and Thomas, Dennis C and Divé, Iris and Weber, Katharina J and Prinz, Vincent and Jussen, Daniel and Deelchand, Dinesh K and Oeltzschner, Georg and Ronellenfitsch, Michael W and Steinbach, Joachim P and Hattingen, Elke and Pilatus, Ulrich and Wenger, Katharina J},
title = {{In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T}},
journal = {Cancer \& metabolism},
year = {2026},
month = apr,
volume = {14},
number = {1},
pages = {10},
publisher = {BMC},
issn = {2049-3002},
doi = {10.1186/
url = {https://
pmid = {42001191},
pmcid = {PMC13091267}
}
RIS
TY - JOUR
AU - Alcicek, Seyma
AU - Manzhurtsev, Andrei
AU - Thomas, Dennis C
AU - Divé, Iris
AU - Weber, Katharina J
AU - Prinz, Vincent
AU - Jussen, Daniel
AU - Deelchand, Dinesh K
AU - Oeltzschner, Georg
AU - Ronellenfitsch, Michael W
AU - Steinbach, Joachim P
AU - Hattingen, Elke
AU - Pilatus, Ulrich
AU - Wenger, Katharina J
TI - In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T
T2 - Cancer & metabolism
J2 - Cancer Metab
PY - 2026
DA - 2026/
VL - 14
IS - 1
SP - 10
SN - 2049-3002
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T",
"container-title": "Cancer & metabolism",
"author": [
{
"family": "Alcicek",
"given": "Seyma"
},
{
"family": "Manzhurtsev",
"given": "Andrei"
},
{
"family": "Thomas",
"given": "Dennis C"
},
{
"family": "Divé",
"given": "Iris"
},
{
"family": "Weber",
"given": "Katharina J"
},
{
"family": "Prinz",
"given": "Vincent"
},
{
"family": "Jussen",
"given": "Daniel"
},
{
"family": "Deelchand",
"given": "Dinesh K"
},
{
"family": "Oeltzschner",
"given": "Georg"
},
{
"family": "Ronellenfitsch",
"given": "Michael W"
},
{
"family": "Steinbach",
"given": "Joachim P"
},
{
"family": "Hattingen",
"given": "Elke"
},
{
"family": "Pilatus",
"given": "Ulrich"
},
{
"family": "Wenger",
"given": "Katharina J"
}
],
"container-title-short":
"volume": "14",
"issue": "1",
"page": "10",
"DOI": "10.1186/
"PMID": "42001191",
"PMCID": "PMC13091267",
"ISSN": "2049-3002",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
18
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1111/jon.70146
- Pitfalls in 2HG Detection With TE-Optimized MRS at 3T.Journal: Journal of neuroimaging : official journal of the American Society of NeuroimagingIn common: structural MRI / diffusion, clinical / translational, other condition, 2 references, author Seyma Alcicek
- [2] doi:10.1002/mrm.70030 [code]
- A data-driven algorithm to determine &
lt;sup& gt;1& lt;/ sup& gt;H-MRS basis set composition. Journal: Magnetic resonance in medicineIn common: structural MRI / diffusion, author Seyma Alcicek - [3] doi:10.1186/s10194-021-01352-1 [code]
- Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time.Journal: The journal of headache and painIn common: structural MRI / diffusion, clinical / translational, 3 references
- [4] doi:10.1093/cercor/bhae046 [code]
- The developmental trajectory of 1H-MRS brain metabolites from childhood to adulthood.Journal: Cerebral cortex (New York, N.Y. : 1991)In common: structural MRI / diffusion, 3 references
- [5] doi:10.1038/s41598-025-22754-0
- Small molecular weight polyfluoroalkyl phosphonates induce ROS-mediated cytotoxicity in glioblastoma cells: a molecular mechanism study.Journal: Scientific reportsIn common: other condition, 3 references
- [6] doi:10.14336/ad.2025.0334 [code]
- GABA Levels Are Significantly Reduced in the Visual, Motor, and Auditory Cortex of Patients with Mild Cognitive Impairment.Journal: Aging and diseaseIn common: structural MRI / diffusion, 3 references
- [7] doi:10.1002/nbm.4702 [code]
- Comparison of seven modelling algorithms for γ-aminobutyric acid-edited proton magnetic resonance spectroscopy.Journal: NMR in biomedicineIn common: structural MRI / diffusion, 3 references
- [8] doi:10.1093/neuonc/noab269
- Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.Journal: Neuro-oncologyIn common: other condition, 4 references
- [9] doi:10.3389/fpsyt.2022.904845 [code]
- The association between language-based task-functional magnetic resonance imaging hemodynamics and baseline GABA+ and glutamate-glutamine measured in pre-supplementary motor area: A pilot study in an aging model.Journal: Frontiers in psychiatryIn common: structural MRI / diffusion, 3 references
- [10] doi:10.1038/s41598-022-10114-1
- Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas.Journal: Scientific reportsIn common: clinical / translational, other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
